© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Experts in the management of migraine discuss the prevalence of individuals taking acute migraine therapy and enumerate the various classes of agents available.
A discussion on the differences between acute and preventive migraine treatment, and the impact of treatment on quality of life.
April 22nd 2021, 12:45pm
Research presented at the American Academy of Neurology's annual meeting indicates some air pollutants may be associated with increased rates of migraine prevalence and severity.
April 19th 2021, 9:05pm
Data from a single health system show women who present to the emergency department for headache tend to do so during the preovulatory interval of their menstrual cycle.
April 13th 2021, 7:45pm
Results of a questionnaire-based study show higher body mass index (BMI) is associated with worse migraine symptoms and comorbidities.
April 12th 2021, 3:42pm
Results from a questionnaire-based study indicated an association between a history of abuse and increased sensory hypersensitivity symptoms among migraineurs.
April 7th 2021, 1:00pm
A review published in Neuropsychiatric Disease and Treatment highlights the lack of research on migraine prevalence and symptoms among postmenopausal women.
April 1st 2021, 5:38pm
Researchers used deidentified real-world data to assess characteristics of patients who have received erenumab since its approval.
March 30th 2021, 6:51pm
A cross-sectional study explores the relationship between magnesium, calcium dietary intake, and migraine among men and women.
March 23rd 2021, 4:41pm
Randomized clinical trial results published in Cephalalgia show that trans-nasal high-flow dry gas therapy may play a role in reducing migraine-associated pain.
March 22nd 2021, 5:15pm
Compared with healthy controls, patients with episodic migraine and patients with chronic migraine exhibited differing structural brain network characteristics, potentially indicating maladaptive reorganizations of headache-related brain circuits which could lead to migraine attacks or secondary alterations to pain.
March 17th 2021, 4:30pm
Results of a scoping review of 19 studies indicate estrogen likely plays a key role in migraine pathogenesis but affects patients in different ways depending on past medical history, age, and use of hormonal therapy.